Hmg Biologics

HMG Biologics is a private biotechnology company based in Boca Raton, Florida, specializing in the development of biosimilars and biobetters. The company focuses on high-value monoclonal antibodies used in oncology and immunology, aiming to improve patient access to essential therapies through more affordable pricing. HMG Biologics leverages advanced analytical characterization and process development to ensure its candidates meet the rigorous standards for biosimilarity. The firm's pipeline includes biosimilar versions of blockbuster drugs such as bevacizumab and adalimumab. Led by Dr. H. Michael Gelfand, the company operates within a network of life science entities focused on innovative biologic solutions and intellectual property.